Psoriasis prevalence among the 2009 AAD National Melanoma/Skin Cancer Screening Program participants

Journal of the European Academy of Dermatology and Venereology

Volumn 27, Issue 6, 2013, Pages 680-685

  Lima, X T ^a   Minnillo, R ^b   Spencer, J M ^c   Kimball, A B ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Society for Investigative Dermatology   (United States)

^c American Academy of Dermatology's Melanoma   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; FEMALE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; SKIN CANCER; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; PREVALENCE; PROGRAM EVALUATION; PSORIASIS; SKIN NEOPLASMS; YOUNG ADULT;

EID: 84877631561     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2012.04531.x     Document Type: Article

References (14)

1. Dalgard F, Svensson A, Holm JO, Sundby J,. Self-reported skin complaints: validation of a questionnaire for population surveys. Br J Dermatol 2003; 149: 794-800.
2. Kuh D, Ben-Shlomo Y, Lynch J, Hallqvist J, Power C,. Life course epidemiology. J Epidemiol Community Health 2003; 57: 778-783.
3. Stern RS, Nijsten T, Feldman SR, Margolis DJ, Rolstad T,. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 2004; 9: 136-139.
4. Gelfand JM, Stern RS, Nijsten T, et al. The prevalence of psoriasis in African Americans: results from a population-based study. J Am Acad Dermatol 2005; 52: 23-26.
5. Kurd SK, Gelfand JM,. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004. J Am Acad Dermatol 2009; 60: 218-224.
6. Jagou M, Bastuji-Garin S, Bourdon-Lanoy E, Penso-Assathiany D, Roujeau JC,. Poor agreement between self-reported and dermatologists' diagnoses for five common dermatoses. Br J Dermatol 2006; 155: 1006-1012.
7. Menter A, Gottlieb A, Feldman SR, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol 2008; 58: 826-850.
8. Gladman DD, Mease PJ, Ritchlin CT, et al. Adalimumab for long-term treatment of psoriatic arthritis: forty-eight week data from the adalimumab effectiveness in psoriatic arthritis trial. Arthritis Rheum 2007; 56: 476-488.
9. Woolacott N, Bravo Vergel Y, Hawkins N, et al. Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation. Health Technol Assess 2006; 10: iii-iv, xiii-xvi, 1-239.
10. Gelfand JM, Gladman DD, Mease PJ, et al. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 2005; 53: 573-577.
11. US census annual estimates for age. URL http://www.census.gov/popest/ data/historical/2000s/vintage-2008/index.html (last accessed: 10 December 2009).
12. US census annual estimates for gender and race. URL http://www.census. gov/popest/data/historical/2000s/vintage-2008/index.html (last accessed: 10 December 2009).
13. US census data for health insurance. URL http://www.census.gov/prod/ 2009pubs/p60-236.pdf (last accessed: 10 December 2009).
14. Raychaudhuri SP, Farber EM,. The prevalence of psoriasis in the world. J Eur Acad Dermatol Venereol 2001; 15: 16-17.